(Q46028800)
Statements
1 reference
A randomized, double-blind, placebo-controlled phase II study of vandetanib plus docetaxel/prednisolone in patients with hormone-refractory prostate cancer. (English)
1 reference
József Horti
1 reference
Anders Widmark
1 reference
Arnulf Stenzl
1 reference
Miriam H Federico
1 reference
Raymond P Abratt
1 reference
Nick Sanders
1 reference
Gillian M Pover
1 reference
István Bodrogi
1 reference
1 April 2009
1 reference
24
1 reference
175-180
1 reference
2
1 reference
Identifiers
1 reference
1 reference